WaferGen Q1 Revenues Rise Sharply; Company Files Prospectus for Offering by Shareholders | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen BioSystems said in a regulatory document that revenues for its first quarter more than doubled year over year.

It separately also announced a stock sale by shareholders of up to more than 112 million shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.